Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Methamphetamine (METH) exerts significant neurotoxicity in experimental animals and humans when taken at high doses or abused chronically. Long-term abusers have decreased dopamine levels, and they are more likely to develop Parkinson’s disease (PD). To date, few medications are available to treat the METH-induced damage of neurons. | Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity
